Chitr Sitthi‐Amorn

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study

Annika Rosengren, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet · 2004 · 2.4K citations

Cardiovascular Epidemiology, Cardiovascular Disease, Global Health +12

Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among Asians

Ganesan Karthikeyan, Koon Teo, Shofiqul Islam et al. · Journal of the American College of Cardiology · 2009 · 212 citations

Metabolic Syndrome, Cardiovascular Epidemiology, Cardiovascular Disease +12

Strengthening health research capacity in developing countries: a critical element for achieving health equity Commentary: Health research and human development in Papua New Guinea Commentary: Does strengthening research capacity improve health equity?

Chitr Sitthi‐Amorn · BMJ · 2000 · 156 citations · Full text

Prevention of chronic kidney and vascular disease: Toward global health equity—The Bellagio 2004 Declaration

John H. Dirks, Dick de Zeeuw, Sanjay Kumar Agarwal et al. · Kidney International · 2005 · 122 citations

Vascular Disease, Preventive Medicine, Renal Disease +13